# To Determine Whether Galactomannan Test Will Help to Detect Fungal Infections Early and Hence Start Treatment Early

> **NCT00361517** · PHASE3 · COMPLETED · sponsor: **Singapore General Hospital** · enrollment: 47 (actual)

## Conditions studied

- Aspergillosis

## Interventions

- **BEHAVIORAL:** Galactomannan antigen monitoring, Aspergillus PCR
- **OTHER:** blood draws
- **OTHER:** blood draws for GM monitoring
- **DRUG:** Amphotericin-B deoxycholate
- **OTHER:** blood test
- **OTHER:** Blood test

## Key facts

- **NCT ID:** NCT00361517
- **Lead sponsor:** Singapore General Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-06-01
- **Primary completion:** 2007-10-30
- **Final completion:** 2009-06-30
- **Target enrollment:** 47 (ACTUAL)
- **Last updated:** 2018-09-26

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00361517

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00361517, "To Determine Whether Galactomannan Test Will Help to Detect Fungal Infections Early and Hence Start Treatment Early". Retrieved via AI Analytics 2026-09-03 from https://api.ai-analytics.org/clinical/NCT00361517. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*